发明名称 Combination Immunotherapy for the Treatment of Cancer
摘要 Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.
申请公布号 US2016244524(A1) 申请公布日期 2016.08.25
申请号 US201615145780 申请日期 2016.05.03
申请人 Board of Regents, The University of Texas System ;Memorial Sloan-Kettering Cancer Center 发明人 Allison James;Sharma Padmanee;Quezada Sergio A.;Fu Tihui
分类号 C07K16/28;A61K38/17;A61K39/395 主分类号 C07K16/28
代理机构 代理人
主权项 1. A method of treating cancer in a patient comprising administering to the patient simultaneously or sequentially a composition comprising a blocking agent to a T cell inhibitory receptor and an agonist to ICOS.
地址 Austin TX US